PureTech Health (NASDAQ:PRTC) Shares Up 0.6% - What's Next?

Shares of PureTech Health PLC Sponsored ADR (NASDAQ:PRTC - Get Free Report) traded up 0.6% during trading on Monday . The stock traded as high as $17.50 and last traded at $17.25. 1,697 shares were traded during trading, a decline of 66% from the average session volume of 5,016 shares. The stock had previously closed at $17.15.

PureTech Health Trading Up 1.6%

The stock's fifty day moving average is $17.79 and its two-hundred day moving average is $18.06.

Hedge Funds Weigh In On PureTech Health

An institutional investor recently raised its position in PureTech Health stock. Pentwater Capital Management LP increased its stake in PureTech Health PLC Sponsored ADR (NASDAQ:PRTC - Free Report) by 39.2% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 33,560 shares of the company's stock after purchasing an additional 9,449 shares during the quarter. Pentwater Capital Management LP owned approximately 0.14% of PureTech Health worth $664,000 as of its most recent filing with the Securities and Exchange Commission. 0.04% of the stock is currently owned by institutional investors and hedge funds.

About PureTech Health

PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. The company is developing LYT-100, which is under Phase 2 stage, to treat idiopathic pulmonary fibrosis (IPF); and LYT-200, a IgG4 monoclonal antibody, currently under Phase 1/2 stage, targeting galectin-9 for treating solid tumors and hematological malignancies.